Jay Stoudemire, PhD

Jay began to consult for Triumvira in 2018 to contribute to the execution and oversight of preclinical study protocols. Dr. Stoudemire has 25+ years industry experience in both biotech and well-established pharmaceutical environments with a record of developing and leading the strategy and execution of programs to support the preclinical evaluation of biologic and small molecule drug candidates from lead optimization to product approval across diverse therapeutic areas. He received his PhD in Microbiology from the University of Miami and completed a postdoctoral fellowship at the Cardiovascular Research Institute at the University of San Francisco. He established a consulting group, Nonclinical Development Consultants, LLC in 2018.